Back to Selection     Print       Date : 30 Jun 2025
Fund Summary
Baroda BNP Paribas Midcap Fund Reg (G)
[Equity: Mid Cap]  
 
Fund Details
Fund Type Growth Launch Date 02-May-2006
Corpus(Cr.) 2213.0 Latest NAV 101.0492 As on 30-07-2025
Equity(%) 92.61 52 Week High 107.001
Debt(%) 7.39 52 Week Low 86.5477
Others(%) 0.0 Exit Load -
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.00
Scheme Benchmark NIFTY Midcap 150 TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Himanshu Singh
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The Scheme seeks to generate long-term capital appreciation by investing primarily in companies with high growth opportunities in the mid capitalization segment. The fund will emphasize on companies that appear to offer opportunities for long-term growth and will be inclined towards companies that are driven by dynamic style of management and entrepreneurial flair.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 15.28%
Top 10 Holdings 26.52%
Top 25 Holdings 55.45%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Banking & Financial 13.62
Pharma & Biotech 11.78
Automobile 10.26
Energy 8.55
Cash 6.51
Software & Services 6.27
Agricultural & Farm Machinery 4.41
Miscellaneous 4.37
Fertilisers 3.94
Healthcare 3.89
Retail 3.3
Technology 2.88
Construction 2.63
Food Beverage & Tobacco 2.44
Chemicals 2.18
Petroleum Products 2.18
Oil & GAS 2.0
SERVICES 1.89
Consumer Non Durable 1.33
Textiles 1.23
Consumer Durables 1.14
Metals 1.13
Telecom 1.1
SOV 0.88
Derivatives 0.09
 
 
 
 
 
Portfolio Metrics
PB Ratio 4.21
PE Ratio 30.73
 
Top 25 Holdings
Holdings Net Asset(%)
Clearing Corporation of India Limited 4.61
PB Fintech Limited 2.88
Hitachi Energy India Limited 2.71
GE T&D INDIA LIMITED 2.67
Federal Bank Limited 2.41
Indian Bank 2.33
Phoenix Mills Limited 2.29
Abbott India Limited 2.26
NAVIN FLUORINE INTERNATIONAL L 2.18
Hindustan Petroleum Corp. Ltd. 2.18
Persistent Systems Limited 2.18
Bharat Heavy Electricals Limited 2.17
Coromandel International Limited 2.09
Glaxosmithkline Pharma Ltd 2.09
Oracle Financial Ser Software Ltd. 2.03
Sundaram Finance Limited 1.99
LIC Housing Finance Limited 1.96
Net Receivable / Payable 1.90
P I INDUSTRIES LIMITED 1.85
Escorts Kubota Limited 1.81
Fortis Health Care Ltd 1.80
Alkem Laboratories Limited 1.79
CRISIL 1.78
IPCA Laboratories Limited 1.76
Max Healthcare Institute Limited 1.73

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-1.02% 7.01% 8.09% -2.10%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
-2.43% 2.80% 7.76% 1.27%
 
Scheme Benchmark [NSE - Nifty Midcap 150 TRI]
-1.93% 8.64% 10.77% -0.41%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
21.93% 21.03% 26.17% 14.40%
 
 
13.82% 14.44% 18.90% 12.79%
 
 
24.75% 25.08% 30.77% 18.01%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
 
Back to Selection